Synonyms: MEN-1309 | MEN1309 | OBT-076
Compound class:
Synthetic organic
|
No information available. |
Summary of Clinical Use ![]() |
OBT076 is an investigational stage oncology agent. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT04064359 | Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors | Phase 1 Interventional | Oxford BioTherapeutics Ltd | ||
NCT05930951 | Study of OBT076 Associated or Not in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck | Phase 1 Interventional | Groupe Oncologie Radiotherapie Tete et Cou |